 |
 |
Gary Hutchinson
Entrepreneur in Residence
Mr. Hutchinson is an entrepreneurial executive with over 25 years of experience in the healthcare technology field. His experience includes founder and CEO, board directorships, investment advisor and consultant for numerous healthcare and technology-oriented start up’s as well as established healthcare manufacturing companies. As an investment advisor, Hutchinson has worked with Hambrecht & Quist, Houlihan Lokey Howard & Zukin, Convergent Ventures, WR Hambrecht & Co. and Water Street Healthcare Partners. Gary Hutchinson is the CEO of ThelioPulse, a spin-off company from the Alfred E. Mann Institute at USC that treats skin lesions with nanopulsed energy. Mr. Hutchinson also plays an advisory role with AMI to develop business plans to raise capital for technologies developed at the Institute.
Mr. Hutchinson’s operating experience includes President and CEO of Precision Dynamics Corporation (PDC), the leading manufacturer of healthcare and patron management identification solutions from 2002 to October 2010. At that time, he assumed a directorship and executive advisory role through the sale of the company to Brady Corporation in December 2012. Under Hutchinson’s CEO direction, PDC grew from $43M to $112M in sales / $2M to $16M in EBITDA. During this time, Hutchinson established European headquarters in Brussels, Belgium; developed manufacturing operations in Tijuana, Mexico; acquired the wristband product line from Hollister, Inc. (Libertyville, IL); acquired TimeMed Labeling Systems, Inc. (Burr Ridge, IL), and partnered with Water Street Healthcare Partners, a Chicago private equity firm. Mr. Hutchinson is also on the Board of Directors of Proa, a startup company that commercializes medical devices.
Prior to PDC, Hutchinson was a founder of Zymed Medical Systems (now Philips Medical Systems, acquired 2000). Through technology development and strategic alliances the company became the industry leader in Ambulatory Monitoring and Arrhythmia Detection Algorithms. The company grew to $25M in sales / $5M in EBITDA. Following the acquisition Hutchinson served as VP Cardiology Products for Philips Medical Systems. The $200M business unit was responsible for manufacturing, research and development, sales and marketing world-wide for non-invasive cardiology products. Hutchinson’s experience also includes serving on various Advisory Boards including ORFID, an early stage company in the field of organic semiconductors and polymer-based RFID (radio frequency identification) devices developed at UCLA. Gary’s Board of Director experience includes Advamed, a healthcare industry advocacy organization and Quinton Instruments, a leading company in Stress Testing, Cardiac Rehab and Cardiac Imaging Systems. Further he was an investor with HP, WRHambrecht & Zymed leading a buyout of Quinton from American Home Products.
Mr. Hutchinson’s community service experience includes serving on the Board of Directors for Big Brothers and Big Sisters of Greater Los Angeles and Louisville High School Finance Council in Woodland Hills, CA. He is a graduate of Ohio State.
|
